SCHEDULE: Diveroli Investment Group Discloses 1.83% Stake in PetMed Express

Diveroli Investment Group LLC and Kingbird Ventures LLC have disclosed a 1.83% beneficial ownership stake in PetMed Express, Inc., signaling potential future influence.

Summary

• Diveroli Investment Group LLC and Kingbird Ventures LLC (the "Reporting Persons") have filed a Schedule 13D, disclosing beneficial ownership of 391,757 shares of PetMed Express, Inc. common stock.
• This stake represents 1.83% of the Issuer's outstanding common stock, based on 21,400,495 shares as of January 30, 2026.
• The Reporting Persons utilized their own investment funds for the acquisition of these shares.
• They intend to review their investment based on various factors, including the Issuer's business, financial condition, and market conditions.
• The Reporting Persons may acquire additional shares or dispose of current holdings in the future.
• They may also express views on the Issuer's performance, valuations, and potential strategic transactions through press releases or reports.
• Currently, they have not formulated specific plans for extraordinary corporate transactions, changes to the board or management, or material changes to the Issuer's capitalization or business structure.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as a new investment group taking a significant stake often signals potential for increased shareholder advocacy or strategic review, which could unlock value for PetMed Express.

Positives

• A significant investor group has identified PetMed Express as an attractive investment, acquiring a 1.83% stake.
• The Reporting Persons' stated intent to review the investment and potentially engage with management could lead to strategic improvements or enhanced shareholder value.

Negatives

• The filing itself does not contain negative financial or operational news from PetMed Express, but rather an ownership disclosure.

Risks

• The Reporting Persons may acquire additional securities or dispose of their current holdings, which could impact the stock price.
• Their potential influence over corporate activities, including expressing views on performance and strategic transactions, could lead to activist investor scenarios.

Future Outlook

The Reporting Persons intend to continuously review their investment in PetMed Express, Inc. based on various factors, including the company's business, financial condition, and market conditions. They may acquire additional shares or dispose of their current holdings and may express their views on the Issuer's performance and potential strategic transactions.

Management Comments

• "As the holders of a significant interest in the Issuer, the Reporting Persons may have influence over the corporate activities of the Issuer."
• "The Reporting Persons from time to time intends to review their investments in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the shares of common stock of the Issuer (the "Shares") in particular, as well as other developments and other investment opportunities."
• "Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time."
• "If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the market price of the Shares or otherwise, they may acquire Shares or other securities of the Issuer either in the open market or in privately negotiated transactions."
• "Similarly, depending on market and other factors, the Reporting Persons may determine to dispose of some or all of the Shares currently owned by the Reporting Persons or otherwise acquired by the Reporting Persons either in the open market or in privately negotiated transactions."
• "The Reporting Persons may also issue press releases and/or reports expressing their views and concerns regarding the Issuer's performance, valuations of the Issuer, investor interest in the Issuer, and potential strategic transactions involving the Issuer."

Industry Context

StockSavvy.ai notes that the pet care industry, including online pharmacies like PetMed Express, has seen increased investor interest, particularly from groups looking for undervalued assets or opportunities for strategic change. The disclosure of a significant stake by an investment group often signals a belief in potential upside or a desire to influence corporate strategy, which is a common trend in sectors undergoing consolidation or facing competitive pressures.

Comparison to Industry Standards

• A 1.83% stake is a notable position for an investment group, though not typically considered an activist stake (which often starts around 5% or more) unless accompanied by more aggressive public statements.
• Compared to other activist filings, this stake is relatively small, suggesting a potential initial position rather than an immediate aggressive campaign. For example, larger activist funds like Starboard Value or Elliott Management often disclose initial stakes of 5-10% or more in target companies such as Salesforce or Marathon Petroleum to exert significant pressure.
• The stated intent to review the investment and potentially influence corporate activities is standard language for Schedule 13D filings by investment groups, similar to disclosures made by funds like ValueAct Capital in companies like Microsoft or Rolls-Royce, where they seek to engage constructively with management.

Stakeholder Impact

• Shareholders: Potential for increased shareholder advocacy and strategic review by the new investment group, which could lead to value creation or changes in company direction.
• Management/Board: May face increased scrutiny or engagement from the Reporting Persons regarding corporate strategy, performance, and governance.

Next Steps

• The Reporting Persons will continue to review their investment in PetMed Express, Inc.
• They may acquire additional shares or dispose of existing holdings based on market conditions and the Issuer's performance.
• They may issue press releases or reports to express their views on the Issuer's performance, valuations, and potential strategic transactions.

Key Dates

Recommendation

The disclosure of a new 1.83% stake by Diveroli Investment Group and Kingbird Ventures in PetMed Express suggests a belief in the company's potential, but the stake is not yet large enough to guarantee immediate activist pressure or significant strategic shifts. While the potential for future engagement and value creation exists, the filing itself does not provide enough concrete information to warrant a "buy" recommendation, nor does it indicate negative developments that would suggest a "sell." Therefore, a "hold" recommendation is appropriate as investors await further actions or communications from the Reporting Persons or PetMed Express.

Keywords

PetMed Express, PMED, Schedule 13D, Diveroli Investment Group, Kingbird Ventures, Beneficial Ownership, Activist Investor, Shareholder Stake, Investment Group, Pet Supplies, Animal Health